These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 12621786

  • 1. [Role of other than renin-angiotensin system genes in the development of renal failure].
    Zychma M, Gumprecht J, Grzeszczak W, Moczulski D, Zukowska-Szczechowska E.
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():53-4. PubMed ID: 12621786
    [No Abstract] [Full Text] [Related]

  • 2. [Role of renin-angiotensin system genes in the development of renal failure].
    Gumprecht J, Grzeszczak W, Zychma M, Zukowska-Szczechowska E.
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():51; discussion 52. PubMed ID: 12621785
    [No Abstract] [Full Text] [Related]

  • 3. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
    Buraczynska M, Ksiazek P, Drop A, Zaluska W, Spasiewicz D, Ksiazek A.
    Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
    [Abstract] [Full Text] [Related]

  • 4. Genetic polymorphisms of renin-angiotensin system and progression of interstitial nephritis.
    Buraczyńska M, Grzebalska A, Spasiewicz D, Orłowska G, Ksiazek A.
    Ann Univ Mariae Curie Sklodowska Med; 2002 Apr; 57(2):330-6. PubMed ID: 12898858
    [Abstract] [Full Text] [Related]

  • 5. [Experimental genetic modifications in the renin-angiotensin and kallikrein-kinin systems: significance for understanding cardiovascular regulation and study of genetic determinism of human diseases].
    Meneton P, Alhenc-Gelas F.
    Nephrologie; 1998 Apr; 19(7):385-9. PubMed ID: 9857372
    [Abstract] [Full Text] [Related]

  • 6. [Renal sclerosis and its treatment. Conclusions].
    Ardaillou R.
    J Soc Biol; 2002 Apr; 196(4):293-4. PubMed ID: 12645298
    [No Abstract] [Full Text] [Related]

  • 7. Low renin-angiotensin system activity gene polymorphism and dysplasia associated with posterior urethral valves.
    Peruzzi L, Lombardo F, Amore A, Merlini E, Restagno G, Silvestro L, Papalia T, Coppo R.
    J Urol; 2005 Aug; 174(2):713-7. PubMed ID: 16006956
    [Abstract] [Full Text] [Related]

  • 8. Polymorphism in angiotensin II receptor genes and hypertension.
    Baudin B.
    Exp Physiol; 2005 May; 90(3):277-82. PubMed ID: 15640279
    [Abstract] [Full Text] [Related]

  • 9. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
    Akman B, Tarhan C, Arat Z, Sezer S, Ozdemir FN.
    Ren Fail; 2009 May; 31(3):196-200. PubMed ID: 19288324
    [Abstract] [Full Text] [Related]

  • 10. Model for gene-environment interaction: the case for dialysis.
    Liangos O, Balakrishnan VS, Jaber BL, DialGene Consortium.
    Semin Dial; 2005 May; 18(1):41-6. PubMed ID: 15663764
    [Abstract] [Full Text] [Related]

  • 11. [Analyses of genetic risk factors associated to chronic nephropathy of renal transplant: genetic polymorphisms of cytokynes, adhesion molecules, platelet-coagulation system and cardiovascular risk markers].
    Cobo M, Barrios Y, Iñigo P, Bigo C, Alvarez A, Martín B, Campistol JM, Hernández D, Salido E, Torres A.
    Nefrologia; 2004 May; 24 Suppl 4():49-56. PubMed ID: 15279387
    [No Abstract] [Full Text] [Related]

  • 12. Family history of end-stage renal disease among hemodialyzed patients in Poland.
    Gumprecht J, Zychma MJ, Moczulski DK, Gosek K, Grzeszczak W.
    J Nephrol; 2003 May; 16(4):511-5. PubMed ID: 14696752
    [Abstract] [Full Text] [Related]

  • 13. Polymorphism of renin-angiotensin system genes in IgA nephropathy.
    Woo KT, Lau YK, Choong LH, Zhao Y, Tan HB, Fook-Chong S, Tan EK, Yap HK, Wong KS.
    Nephrology (Carlton); 2004 Oct; 9(5):304-9. PubMed ID: 15504143
    [Abstract] [Full Text] [Related]

  • 14. Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction.
    Reis K, Arinsoy T, Derici U, Gonen S, Bicik Z, Soylemezoglu O, Yasavul U, Hasanoglu E, Sindel S.
    Clin Transplant; 2005 Feb; 19(1):10-4. PubMed ID: 15659127
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.
    Magistroni R, Manfredini P, Furci L, Ligabue G, Martino C, Leonelli M, Scapoli C, Albertazzi A.
    J Nephrol; 2003 Feb; 16(1):110-5. PubMed ID: 12653106
    [Abstract] [Full Text] [Related]

  • 16. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males.
    Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S, Tokunaga K.
    J Am Soc Nephrol; 2006 Mar; 17(3):823-30. PubMed ID: 16421229
    [Abstract] [Full Text] [Related]

  • 17. Association between the A1166C polymorphism of the angiotensin II receptor type 1 and progression of chronic renal insufficiency.
    Coll E, Campos B, González-Núñez D, Botey A, Poch E.
    J Nephrol; 2003 Mar; 16(3):357-64. PubMed ID: 12832734
    [Abstract] [Full Text] [Related]

  • 18. [Polymorphism of angiotensin II type 1 receptor in terminal renal failure].
    Buraczyńska M, Ksiazek P, Załuska W, Ksiazek A.
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():42; discussion 42-3. PubMed ID: 12621781
    [No Abstract] [Full Text] [Related]

  • 19. Gene polymorphism association studies in dialysis: bone and mineral metabolism.
    Erturk S, DialGene Consortium.
    Semin Dial; 2006 Nov; 19(3):232-7. PubMed ID: 16689975
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.